Fresenius Medical Care AG (FMS)
21.60
+0.19
(+0.89%)
USD |
NYSE |
Oct 21, 11:36
Fresenius Medical Care Research and Development Expense (TTM) : 180.40M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 180.40M |
| March 31, 2026 | 177.53M |
| December 31, 2025 | 178.47M |
| September 30, 2025 | 186.41M |
| June 30, 2025 | 186.29M |
| March 31, 2025 | 192.17M |
| December 31, 2024 | 198.29M |
| September 30, 2024 | 215.91M |
| June 30, 2024 | 229.62M |
| March 31, 2024 | 242.78M |
| December 31, 2023 | 250.73M |
| September 30, 2023 | 242.97M |
| June 30, 2023 | 247.20M |
| March 31, 2023 | 244.02M |
| December 31, 2022 | 239.92M |
| September 30, 2022 | 254.44M |
| June 30, 2022 | 254.24M |
| March 31, 2022 | 257.84M |
| December 31, 2021 | 260.71M |
| September 30, 2021 | 244.97M |
| June 30, 2021 | 235.72M |
| March 31, 2021 | 228.68M |
| December 31, 2020 | 220.67M |
| September 30, 2020 | 212.93M |
| June 30, 2020 | 215.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 205.60M |
| December 31, 2019 | 193.18M |
| September 30, 2019 | 182.29M |
| June 30, 2019 | 157.56M |
| March 31, 2019 | 156.32M |
| December 31, 2018 | 157.36M |
| September 30, 2018 | 156.39M |
| June 30, 2018 | 159.22M |
| March 31, 2018 | 152.98M |
| December 31, 2017 | 148.03M |
| September 30, 2017 | 147.70M |
| June 30, 2017 | 158.75M |
| March 31, 2017 | 159.36M |
| December 31, 2016 | 162.59M |
| September 30, 2016 | 160.09M |
| June 30, 2016 | 151.28M |
| March 31, 2016 | 146.66M |
| December 31, 2015 | 139.68M |
| September 30, 2015 | 128.83M |
| June 30, 2015 | 123.62M |
| March 31, 2015 | 120.14M |
| December 31, 2014 | 120.35M |
| September 30, 2014 | 123.82M |
| June 30, 2014 | 127.75M |
| March 31, 2014 | 127.78M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median